(Q43213519)

16 November 2017

title

Effects of the bisphosphonate risedronate on osteopenia in OASIS-deficient mice (English)

1 reference

16 November 2017

Hiroshi Sekiya

1

1 reference

16 November 2017

Tomohiko Murakami

2

1 reference

16 November 2017

Atsushi Saito

3

1 reference

16 November 2017

Shin-Ichiro Hino

4

1 reference

16 November 2017

Kenji Tsumagari

5

1 reference

16 November 2017

Kimiko Ochiai

6

1 reference

16 November 2017

Kazunori Imaizumi

7

1 reference

16 November 2017

publication date

19 December 2009

1 reference

Journal of Bone and Mineral Metabolism

16 November 2017

published in

1 reference

16 November 2017

volume

28

1 reference

16 November 2017

issue

4

1 reference

16 November 2017

page(s)

384-394

1 reference

https://scigraph.springernature.com/pub.10.1007/s00774-009-0142-y

16 November 2017

exact match

0 references

cites work

Translational control in the endoplasmic reticulum stress response

1 reference

https://api.crossref.org/works/10.1007%2FS00774-009-0142-Y

ER stress and the unfolded protein response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-009-0142-Y

Characterization of porcine osteonectin extracted from foetal calvariae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-009-0142-Y

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00774-009-0142-Y

Osteoprotegerin Regulates Bone Formation through a Coupling Mechanism with Bone Resorption

21 January 2018

1 reference

12 December 2020

Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice

1 reference

12 December 2020

Bisphosphonates: mechanisms of action

1 reference

12 December 2020

Signalling mediated by the endoplasmic reticulum stress transducer OASIS is involved in bone formation

1 reference

12 December 2020

ER stress-mediated apoptosis in a new mouse model of osteogenesis imperfecta

1 reference

12 December 2020

PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation.

1 reference

12 December 2020

The role of collagen in bone strength

1 reference

12 December 2020

The human type I collagen mutation database

1 reference

12 December 2020

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

1 reference

12 December 2020

Identification of a novel gene, OASIS, which encodes for a putative CREB/ATF family transcription factor in the long-term cultured astrocytes and gliotic tissue

1 reference

12 December 2020

Expression of the novel transcription factor OASIS, which belongs to the CREB/ATF family, in mouse embryo with special reference to bone development.

1 reference

12 December 2020

A light and electron microscopic study of osteogenesis imperfecta bone samples, with reference to collagen chemistry and clinical phenotype

1 reference

12 December 2020

Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen

1 reference

12 December 2020

OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes

1 reference

12 December 2020

In vivo effects of bisphosphonates on the osteoclast mevalonate pathway

1 reference

12 December 2020

Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

1 reference

12 December 2020

Osteoclast-derived activity in the coupling of bone formation to resorption.

1 reference

12 December 2020

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

1 reference

12 December 2020

Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI

1 reference

12 December 2020

Buried alive: how osteoblasts become osteocytes

1 reference

12 December 2020

Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse

1 reference

12 December 2020

Tripartite management of unfolded proteins in the endoplasmic reticulum

1 reference

12 December 2020

Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans.

1 reference

12 December 2020

A controlled study of the effects of alendronate in a growing mouse model of osteogenesis imperfecta

1 reference

12 December 2020

CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta

1 reference

12 December 2020

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

12 December 2020

Protein folding in the cell

1 reference

12 December 2020

Setting the standards: quality control in the secretory pathway

1 reference

12 December 2020

Animal models of osteogenesis imperfecta and related syndromes

1 reference

12 December 2020

Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice

1 reference

12 December 2020

Cleavage of the membrane-bound transcription factor OASIS in response to endoplasmic reticulum stress

1 reference

12 December 2020

Reaching a genetic and molecular understanding of skeletal development

1 reference

12 December 2020

Regulation of endoplasmic reticulum stress response by a BBF2H7-mediated Sec23a pathway is essential for chondrogenesis

1 reference

12 December 2020

Drug insight: Bisphosphonates for postmenopausal osteoporosis

1 reference

12 December 2020

Osteoclast-osteoblast communication

1 reference

12 December 2020

Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts

1 reference

12 December 2020

Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival

1 reference

12 December 2020

Transgenic mouse model of the mild dominant form of osteogenesis imperfecta

1 reference

12 December 2020

Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta

1 reference

12 December 2020

ER stress and neurodegenerative diseases

1 reference

12 December 2020

Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta

1 reference

12 December 2020

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta

1 reference

12 December 2020

10.1007/S00774-009-0142-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

16 November 2017

1051241741

0 references

1 reference